High materiality9/10
BlossomHill Therapeutics initiated with an Outperform at Leerink
Why it may matterVerify against the original reporting
initiation_outperform
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Leerink Partners initiates coverage on BLSM with an Outperform rating; target $36; current price $18.30.
- Leerink initiates BLSM with Outperform; PT $36; price $18.30.
Key facts
- 01
Target: $36
- 02
Posted price: $18.3
- 03
Analyst firm: Leerink Partners
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.